¹[

¹[¦bECFªº¿@«×¤ñ¸û§C¡A¬ù3.5-5.0mmol/L¡A²Ó­M¤º¤ñ¸û°ª¡A¤j¬ù120-150mmol/L¡A²Ó­M½¤ºû«ùùØ­±¤ñ¥~­±¹qÀ£§C50-90mV¡A¬O¥H²Ó­M½¤¤º¥~³Ì®e©ö¥æ´«ªºÂ÷¤lºû«ù³o¤@­Ó¹qÀ£®t¡A³o´N¬O¹[Â÷¤l¡A¦]¦¹¦å¼ß¤¤¹[Â÷¤l¤Ó°ª©ÎªÌ¤Ó§C¡A³£·|¼vÅT¨ì¯«¸g¡A¦Ù¦×ªº¬¡©Ê¡C
¹[Â÷¤l¬JµM²Ó­M¥~¤ñ¸û§C¡A¥¦­n¿é°e¤J²Ó­M¤º®É¡A­n¥Î¨ìNa+~K+ ATPase ¥D°Ê¹B¿é¡A´N¬O±NK+±À¤J²Ó­M¤º¡ANa+°e¥X²Ó­M¡C¼vÅT²Ó­M¥æ´«ªº¦]¯À¤£¤Ö¡A1.·í¹[¥[¤J²Ó­M¥~®É¡A¦³¤@¥b³Q°e¤J²Ó­M¤º¡A¤@¥b¥ÑµÇŦ±Æ¥X¡C2.¦b¦å¼ß°¾ÆPªº®É­Ô²Ó­M¤ºªºH+·|ÂX´²¨ì¦å¼ß¤¤¡A¥æ´«¹[¡A¦Ó¥BµÇŦ¹[ªº±Æ¥X¼W¦h¡A³y¦¨§C¹[¦å¯g(hypokalaemia)¡F·í¦å¼ß°¾»Ä®É¤è¦V¬Û¤Ï¤Þ°_°ª¹[¦å¯g¡A¦ý³o¥i¯à¥uµo¥Í¦b HCl acidosis¡A¦Ü©ó¨ä¥L¦³¾÷»Äªº»Ä¤¤¬r¦plactic acidosis¡Aketoacidosis¡Alactate-­tÂ÷¤l¥i¥H©MH+¥¿Â÷¤l·|¦P®É¶i¤J²Ó­M¡A¦Ó¤£·|±À°ÊK+¶]¨ì²Ó­M¥~­±¨Ó¡C3.Aldosterone¤]·|«P¶i»·ºÝµÇ¤pºÞ²Ó­MÄá¨ú¹[¦A±q§¿²G±Æ¥X¡A¦ý¬O¹ï¨ä¥Lªº²Ó­M¤@¯ë§@¥Î«Ü»´·L¡C4.Insulin ¨Ï²Ó­MÄá¨úK+¡A¦ý³o¤@­Ó§@¥Î»P¦å¿}µLÃö¡C5.Catecholamine«P¶i²Ó­MÄá¨úK+¡A¤]·|³y¦¨§C¹[¦å¯g¡A¨ä§@¥Î¬Oµu¼Èªº¡AÅý¨xÄÀ¥X¹[¡AµM«á¥Ñ¨ä¥L²Ó­M§ó¦³®ÄªºÄá¨ú¡C
µÇŦ¹ï¹[ªº±Æªn¡G¦b¸g¥ÑµÇµ·²y¹LÂo«á¡A>95%¬O¦bªñºÝµÇ¤pºÞ»P¦ë¹p¤óÅs¤Wª@¤ä¦^¦¬¡A§¿²G¤¤ªº¹[¥D­n¬O¦b»·ºÝµÇ¤pºÞ½Õ¸`¤Àªc¥X¥hªº¡C
¼W¥[»·ºÝµÇ¤pºÞ²Ó­M¤ºªºK+¡A´N·|¼W¥[±q³oùؤÀªc¥X¥h¡A±q¤p«K±Æ¥X¡Aaldosterone¤Wª@®É¡A«P¶iK+ªº±Æ¥X¡AÆP¤¤¬rªº¯f¤H¡AH+-K+ªº¥æ´«¡A¤]·|«P¶iK+±qµÇŦ¥X¥h¡A³o­Ó®ÄªG¤ñ¸g¥Ñ«DµÇŦ²Ó­MÄá¨úK+ªº®ÄªG¤j¡A¬O³y¦¨§C¦å¹[ªº¥D¦]¡C¦Ü©ó»·ºÝµÇ¤pºÞ²Ó­M±Æ¥X¹[¤U­°ªº±¡ªp­è¦n¬Û¤Ï¡Aµo¥Í©óAldosterone¹L§C¡A»Ä¤¤¬r¡A¥H¤Î¹[load´î¤Ö®É¡C
¥t¤@¤è­±§¿²G¬y³t¤Wª@¡A¹[ªº±Æ¥X¤Wª@¡A³o¦b¶uload¤Wª@®É¡A§Q§¿¾¯¨Ï¥Î®É¡F¤Ï¤§¬y³t¤U­°©ó²æ¤ô¡AGFR¤U­°¡A«æ©ÊµÇ°IºÜªº¯f¤H¡C
Hyperkalaemia°ª¹[¦å¯gªº­ì¦]«Ü¦h¡A¦ý¬O¤]¥i¥H²Ê²¤ªº¤À¦¨¤T¸s¡A´N¬O1.pseudohyperkalaemia¡A2.¹[¶i¤JECF¼W¥[¡A3.µÇŦ±Æ¥X´î¤Ö¡C
Pseudohyperkalaemia°²©Ê°ª¹[¦å¯g¬O¦]¬°¨Ó¦Û¤@¨Ç¯f¤H¥Õ¦å²y©Î¦å¤pªO«Ü°ª¡A¦b¦å²G¾®©T¨ú±o¦å²Mªº¹Lµ{¤¤¡A²Ó­M¯}Ãa³y¦¨ªº¡A¥t¤@­Ó­ì¦]¬O¦åºÞ¥~·»¦å³y¦¨ªº¡C
¹[¶i¤JECFªº­ì¦]¤£¤Ö¡A­º¥ý¬O²Õ´ªº¯}Ãa¡Aµo¥Í¦b¨®º×¡A¿N¶Ë¡A´c©Ê¸~½F¤Æ¾ÇÀøªk³y¦¨²Ó­M¯}ÃaÄÀ¥X¤j¶qªº¹[¶i¤JECF¡A³o¨Ç¯f¤H±`±`¤S·|¶Ë®`¨ìµÇŦ¡A¨Ï°ª¹[¦å¯g§ó´c¤Æ¡C¨ä¦¸¬O»Ä¤¤¬r¡A²Ó­M¥~ªºH+»P²Ó­M¤ºªºK+¥æ´«¡A¦ý¦b¿}§¿¯fªºKetoacidosis¡A¦å¹[¤Wª@¬Oinsulin¤£¨¬ªº­ì¦]¡A¤£¬OH+-K+¥æ´«ªºµ²ªG¡C¥t¤@¤è­±°ª¦å¶u¯g©M°ª¦å¿}³y¦¨¦å¼ß°ªº¯³zÀ£ªº±¡ªp¡A¤]·|³y¦¨²Ó­M¤ºªº¹[¶i¤JECF¡A¥u¬O¯u¥¿ªº¾÷ÂàÁÙ¤£¬O«Ü²M·¡¡A©Ò³y¦¨ªº¬O¤ñ¸û»´·Lªº°ª¦å¹[¯g¡CÁÙ¦³¤@ºØ¬O¨u¨£ªº¿ò¶Ç¯e¯f¡A¤@¬q®É¶¡´Nµo§@¤@¦¸³Â·ô¡A¦Ù¦×µL¤Oªº¯gª¬¡A°ª¹[¦å¯g¬O¦Ù¦×²Ó­MÄÀ©ñ¹[ªºµ²ªG¡C³Ì«áÁÙ¦³¤@¨ÇÃĪ«¡A¹ï²Ó­M¦³¬r©Ê¡A³y¦¨°ª¹[¦å¯g¡C
¹[¦bµÇŦ±Æ¥X´î¤Öªº±¡§Î¡A³Ì±`¨£ªº¬O«æºC©ÊµÇ°IºÜ¡A¦bºC©ÊµÇ¾÷¯à¤£¥þ®É¡A¾l¯d¦³¥\¯àªºµÇ³æ¦ì·|´£°ª¥»¨­ªº§@¥Î¸ÉÀv¡A¦ý³Ì²×·íµÇ³æ¦ì70-80%¨ü¨ì¯}Ãa®É¡A´N·|²£¥Í°ª¹[¦å¯g¡A¦Ü©ó«æ©ÊªºµÇ°IºÜ¯f¤H¡A°ª¹[¦å¯g¬O±`±`·|¥X²{ªºµ²ªG¡C¥t¤@ºØ»P±Æ¥X´î¤Ö¦³Ãöªº¬OÃĪ«¨Ï¥Îªºµ²ªG¡A¬Y¨Ç§Q§¿¾¯¡A´î¤Ö»·ºÝµÇ¤pºÞ¶uªº¦^¦¬¡A¤]´N§í¨î¹[ªº±Æ¥X¡A¤@¨Ç«DÃþ©T¾J§Üµoª¢ªºÃĪ«¡A¹³Indomethacin¥i¥H§í¨îprostaglandinsªº¦X¦¨¡A¶i¦Ó§í¨îreninªºÄÀ©ñ»Paldosteroneªº¦X¦¨¡A¦]¦¹»·ºÝµÇ¤pºÞ¹ï©ó¶uªº¦A§l¦¬´î¤Ö¡AµLªk¦³®Ä²vªº±Æ¥X¹[¡A¨ä¥L§í¨îaldosteroneªºÃĪ«³£·|³y¦¨hyperkalaemia¡C¨­Åé¦b»s³y¤Àªcrenin¡Aaldosterone¤£¨¬®É¤]·|¦³¬Û¦Pªºµ²ªG¡A³oµo¥Í¦b½Ñ¦pÃþ©T¾J»s³yªº»Ã¯À¯Ê·l¡A¥çºÙ§@Mineralocorticoid deficiency syndromes¡A¦Óinterstitial nephritis¡ASLE¡AÅIª¬²Ó­M¡A¾ý¯»¼ËÅܩʯf¡A§¿¸ôªý¶ëµ¥¯e¯f«h¬OAldosterone¡Arenin¥¿±`¡A¦ý¯e¯f³y¦¨»·ºÝµÇ¤pºÞ¨S¦³¤ÏÀ³¡AºÙ¬°Mineralocorticoid resistance syndromes¡C
°ª¦å¹[¯g¤×¨ä¦b¶W¹L6.0mmol/L®É¡Aºë¯«¿ù¶Ã¡A¦Ù¦×°I®z¡Aäú¤ß¡A¹Ã¦R¡A³Â·ô©Êªº¸z¶ë¡A·Pı­Ë¿ù¡A¤ß²v¤£¾ã¡A¤ß¹q¹Ïªí²{°ªªºTªi¡AQRS¤ÎPR intervalÅܼe¡C
§C¹[¦å¯g¡AHypokalaemia³Ì±`¨£©ó§Q§¿¾¯ªºªvÀø¡A¹Ã¦R¡A¤UÂmµ¥­ì¦]¡CÄá¨ú¤£¨¬³y¦¨§C¦å¹[¸I¨ìªº¾÷·|«Ü¤Ö¡A¶È¦bºC©Ê°sºë©Ê¤¤¬r»P¯«¸g©Ê¹½­¹´¿¸g³ø§i¹L¡C¦b¿}§¿¯f¯f¤H¦]¬°K+±q²Ó­M¤ºº|¥X¡Aªø´Áªº±qµÇŦ±Æ¥X¡A·|³y¦¨Å餺¹[ªº¤£¨¬¡A·í¨Ï¥ÎInsulin®É¡A³y¦¨K+¦^¨ì²Ó­M¤º¡A©Ò¥H¦pªG¨S¦³¸É¥R¹[¡A·|³y¦¨ÄY­«ªº§C¹[¦å¯g¡A´c©Ê³h¦å¯f¤H¡A¨Ï¥ÎB12ªvÀø®É¤]­n¦Ò¼{»s³y¬õ¦å²y®É¤j¶q¦^¦¬K+¡A³y¦¨ÄY­«ªº§C¹[¦å¯g¡C¨ä¥L¤]¦³¥¼ª¾­ì¦]ªº¤@¬q®É¶¡µo§@¤@¦¸¦Ù¦×³Â·ôªº§C¹[¦å¯g¡A¥H¤Î¾X¬r©Ê³y¦¨ªºÄY­«§C¹[¦å¯g¡C
§C¹[¦å¯g¡A§Q§¿¾¯¬O¤@¤j¥D¦]¡A­º¥ý¬Ocarbonic anhydrase ªºÃĪ«¡A­°§Csodium bicarbonate¦bªñºÝµÇ¤pºÞªº¦^¦¬¡A¾É­PNa+»PH2O¦^¦¬´î¤Ö¡A¦]¦¹¦b»·ºÝµÇ¤pºÞªºNa+¤Wª@¡A¦]¦¹Na+-K+ªº¥æ´«¤Wª@¡A§¿ªº¬y¶q¤Wª@¡A¯f¤H¨Ï¥Î³oÃþ§Q§¿¾¯·|²£¥Í¥NÁ©ʻĤ¤¬r(µÇŦbicarbonate¬y¥¢)¡A¥H¤Î§C¦å¹[ªºµ²ªG¡C²Ä¤GÃþ¬Othiazide diuretics¡A³o¨Ç§Q§¿¾¯¥D­n§í¨î¦ë¹p¤óÅs¤Wª@¤ä¹ï¶uªº¦^¦¬¡A¦]¦¹»·ºÝµÇ¤pºÞNa+-K+ªº¥æ´«¤Wª@¡AK+±Æ¥X¼W¦h¡ANa+¦^¦¬´î¤Ö¨ë¿Ealdosterone¤Wª@¡A¥[³t»·ºÝµÇ¤pºÞ¦^¦¬¶u¡A±NK+»PH+±À¥X¥h¡Aµ²ªG´N¬O§¿¶q¼W¦h¡A¦å¤¤K+¡AH+´î¤Ö¡A³y¦¨metabolic alkalosis¡C²Ä¤TÃþªº§Q§¿¾¯¤]¬O§@¥Î¦b¦ë¹p¤óÅs¡A¤£¹L¬O§í¨îCl-ªº¦^¦¬¡A¦]¦¹Na+¤]µLªk¤@°_¶i¨Ó¡A³oÃþÃĪ«¤]¬O³y¦¨§C¹[¦å¯g¤Î¥NÁ©ÊÆP¤¤¬r¡A¹Lµ{©Mthiazide¬Ûªñ¡C
ªø®É¶¡ªº¹Ã¦R°£¤F·l¥¢­G»Ä³y¦¨¥NÁ©ÊÆP¤¤¬r¡A¦b»·ºÝµÇ¤pºÞ§@K+-H+ªº¥æ´«¡A¾¨¶q¦^¦¬H+¨Ó¥­¿Å»ÄÆP¡A©Ò¥HK+¬y¥¢¤Wª@¡A¥t¤@¤è­±²æ¤ô³y¦¨Aldosterone¤Wª@¡A¤]¼W¥[K+ªº±Æ¥X¡C¤UÂmªº²GÅ餤bicarbonate¤ÎK+§t¶q³£«ÜÂ×´I¡A¦]¦¹³y¦¨§C¦å¹[¡A¥NÁ©ʻĤ¤¬r¡A¦pªG²æ¤ô®É¤]³y¦¨Äòµo°ªªºAldosterone¡A¶i¤@¨B¥ÑµÇŦ±Æ¥X¹[¡Cªø´Á¨Ï¥Î»´Âm¾¯¤]·|¦³¬Û¦üªºµ²ªG¡A¥t¥~¦b¤j¸zª½¸zªºVillous adenomasµ³¤ò¸¢Àù¡A¥Ñ¸~½F¤Àªc¥X¥h¤j¶qªº¹[¡A¤]·|¦³§C¦å¹[ªºµ²ªG¡C
µÇŦµÇ¤pºÞ¥NÁ©ʻĤ¤¬r¤]¬Oªí²{§C¹[¦å¯g¡A¥i¤À¬°¨âºØ¡A¤@ºØ¬OªñºÝµÇ¤pºÞ»Ä¤¤¬r(Type 2 renal tubular acidosis)¡A¬OªñºÝµÇ¤pºÞµLªk¤ÀªcH+¥X¥h¡A¦]¬°³o¬O¦^¦¬bicarbonate©Ò¥²¶·ªº¡A³y¦¨HCO3-±q§¿²G·l¥¢ªº¥NÁ©ʻĤ¤¬r¡A¹[·l¥¢ªº­ì¦]»P«e¤@­¶§Q§¿¾¯(§í¨îcarbonic anhydrase)¨Ï¥Î¬Û¦ü¡C²Ä¤GºØ¬O»·ºÝµÇ¤pºÞ»Ä¤¤¬r(Type 1)¡A³o¬O»·ºÝµÇ¤pºÞ¤Àªc±Æ¥XH+¥¢¥h¥\¯à¡A³y¦¨¥NÁ©ʻĤ¤¬r¡AµÇŦ·l¥¢¹[ªº­ì¦]©|¤£¬O«Ü²M·¡¡C
Aldosterone¼W¥[Na+ªº¦^¦¬¡A¥æ´«K+»PH+±q»·ºÝµÇ¤pºÞ±Æ¥X¡A¦]¦¹Primary¤Îsecondary hyperaldosteronism³£·|³y¦¨¥NÁ©ÊÆP¤¤¬r©M§C¹[¦å¯g¡C
§C¹[¦å¯gªí²{¦Ù¦×°I®z¡A³Â·ô¡A¸x¤Ï®g¥¢±¼¡A¯h­Â¡A¤ß¸õ¹L§Ö¡A¤ß²v¤£¾ã¡A§C¦åÀ£¡A¦³®É«J·|¦h§¿¡A¤ß¹q¹ÏTªi§í¨î¡A¦³®É­Ô§e¤Ï¤è¦V¡AST§í¨î¡AÄY­«ªº®É­Ô¥X²{Uªi¡AQT¤ÎQRSÅܼe¡C